JP2000503667A - アルキルアミノベンゾチアゾールおよび―ベンゾキサゾール誘導体 - Google Patents
アルキルアミノベンゾチアゾールおよび―ベンゾキサゾール誘導体Info
- Publication number
- JP2000503667A JP2000503667A JP9540535A JP54053597A JP2000503667A JP 2000503667 A JP2000503667 A JP 2000503667A JP 9540535 A JP9540535 A JP 9540535A JP 54053597 A JP54053597 A JP 54053597A JP 2000503667 A JP2000503667 A JP 2000503667A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- alkyl
- receptor
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式 式中、 XはOもしくはSであり; nは2、3、4もしくは5であり; R1は水素、C1-6アルキル、C1-6アルキルオキシもしくはハロであり; R2は水素、C1-6アルキル、フェニル、フェニルC1-6アルキルもしくはフェニ ルカルボニルであり; R3およびR4はそれぞれ独立して、水素、ハロ、ニトロ、C1-6アルキル、C1-6 アルキルオキシ、ハロC1-6アルキル、アミノスルホニル、モノもしくはジ(C1 -4 アルキル)アミノスルホニルから選択され;または、 R3およびR4はまた、一緒になって式−CH=CH−CH=CH−の二価の基を 形成しうる、 を有する化合物、そのN−オキシドの形態、製薬学的に許容できる酸付加塩もし くは立体化学的異性体。 2.nが2、3もしくは4である、請求の範囲1に記載の化合物。 3.XがSであり、かつ、R2が水素、C1-6アルキル、フェニルもしくはフェニ ルC1-6アルキルである、請求の範囲1もしくは2に記載の化合物。 4.R2およびR3が水素でありかつR4がクロロである、請求の範囲1もしくは 2に記載の化合物。 5.化合物が、 N−[2−[4−(3,4−ジクロロフェニル)−1−ピペラジニル]エチル] −2−ベンゾチアゾルアミン; N−[2−(4−フェニル−1−ピペラジニル)エチル]−2−ベンゾチアゾル アミン; N−[2−[4−(4−クロロフェニル)−1−ピペラジニル]エチル]−2− ベンゾチアゾルアミン; N−[2−[4−(4−ブロモフェニル)−1−ピペラジニル]エチル]−2− ベンゾチアゾルアミン;それらのN−オキシド、立体異性体もしくは製薬学的に 許容できる酸付加塩、 である、請求の範囲1に記載の化合物。 6.ヨウ素、臭素もしくはフッ素の放射活性同位体である最低1個のハロを有す るか、または最低1個の11C原子もしくはトリチウム原子を有する、請求の範囲 1の記載の化合物。 7.製薬学的に許容できる担体、および、有効成分として、請求の範囲1ないし 5のいずれか一に記載される化合物の有効なドーパミンD4レセプター拮抗量を 含んで成る、製薬学的組成物。 8.製薬学的に許容できる担体が、請求の範囲1ないし5のいずれか一に記載さ れる化合物の有効なドーパミンD4レセプター拮抗量と親密に混合されることを 特徴とする、請求の範囲7に記載の製薬学的組成物の製造方法。 9.薬剤としての使用のための請求の範囲1ないし5のいずれか一に記 載される化合物。 10.a)式(III) 式中nおよびR2ないしR4は請求の範囲1で定義される、 の中間体を、反応不活性溶媒中、場合によっては適する塩基の存在下、また、場 合によっては触媒の存在下に、式(II) 式中Wは適切な反応性脱離基を表し、かつ、XおよびR1は請求の範囲1で定義 される、 の中間体でN−アルキル化すること; b)式(III) 式中nおよびR2ないしR4は請求の範囲1で定義される、 の中間体を、反応不活性溶媒中かつ塩化チオニルの存在下、式(IV) 式中R1は請求の範囲1で定義される、 の中間体と反応させ;こうして式(I−a) の化合物を形成すること、 c)式(VI) 式中R3およびR4は請求の範囲1で定義される、 の中間体を、反応不活性溶媒中、式(VII) 式中R1、R2、nおよびXは請求の範囲1で定義され、かつ、W2は適切な脱離 基である、 の中間体でN−アルキル化すること; d)式(XV)式中X、R1およびR2は請求の範囲1で定義される、 の中間体を、反応不活性溶媒中、適する塩基の存在下に、式(XVI) 式中n、R3およびR4は請求の範囲1で定義され、かつ、W2は適切な脱離基で ある、 の中間体でN−アルキル化すること; e)式(I)の化合物を、技術既知の変換に従って相互に転化すること、および 、さらに、所望の場合は、式(I)の化合物を、酸での処理により治療上活性の 非毒性酸付加塩に転化すること、もしくは逆に、酸付加塩の形態を、アルカリで の処理により遊離塩基に転化すること;そして、所望の場合は、その立体化学的 異性体もしくはN−オキシドを製造すること、 を特徴とする、請求の範囲1に記載される化合物の製造方法。 11.a)請求の範囲1に記載される化合物を放射標識すること; b)前記放射標識化合物を生物学的物質に投与すること; c)放射標識化合物からの放出を検出すること、 の段階を含んで成る、ドーパミンD4レセプターに印を付ける方法。 12.式(I)の放射標識化合物の十分量を適切な組成物で投与することであっ て、それにより前記化合物がドーパミンD4レセプター部位に結合し;および、 放射活性化合物からの放出を検出すること、を特徴とする、器官の画像化方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201282.9 | 1996-05-10 | ||
EP96201282 | 1996-05-10 | ||
PCT/EP1997/002505 WO1997043271A1 (en) | 1996-05-10 | 1997-05-02 | Alkylaminobenzothiazole and -benzoxazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000503667A true JP2000503667A (ja) | 2000-03-28 |
JP3237759B2 JP3237759B2 (ja) | 2001-12-10 |
Family
ID=8223970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54053597A Expired - Lifetime JP3237759B2 (ja) | 1996-05-10 | 1997-05-02 | アルキルアミノベンゾチアゾールおよび―ベンゾキサゾール誘導体 |
Country Status (29)
Country | Link |
---|---|
US (2) | US6103725A (ja) |
EP (2) | EP1325917B1 (ja) |
JP (1) | JP3237759B2 (ja) |
KR (1) | KR100330699B1 (ja) |
CN (1) | CN1074766C (ja) |
AR (1) | AR007079A1 (ja) |
AT (2) | ATE350373T1 (ja) |
AU (1) | AU710175B2 (ja) |
BG (1) | BG64097B1 (ja) |
BR (1) | BR9709065A (ja) |
CA (1) | CA2253453C (ja) |
CZ (1) | CZ295639B6 (ja) |
DE (2) | DE69730962T2 (ja) |
EA (1) | EA001360B1 (ja) |
EE (1) | EE03563B1 (ja) |
ES (2) | ES2230605T3 (ja) |
HK (2) | HK1057044A1 (ja) |
HU (1) | HUP9902993A3 (ja) |
ID (1) | ID16889A (ja) |
IL (1) | IL126968A0 (ja) |
MY (1) | MY117852A (ja) |
NO (1) | NO311027B1 (ja) |
NZ (1) | NZ332309A (ja) |
PL (1) | PL190721B1 (ja) |
SK (1) | SK282919B6 (ja) |
TR (1) | TR199802253T2 (ja) |
TW (1) | TW593290B (ja) |
WO (1) | WO1997043271A1 (ja) |
ZA (1) | ZA974053B (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006117677A (ja) * | 2004-10-22 | 2006-05-11 | Bioprojet | 新規のアリールピペラジン誘導体 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1293804B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
US6281216B1 (en) * | 1998-02-09 | 2001-08-28 | Duphar International Research B.V. | 2-aminoquinoline derivatives having d4-agonistic activity |
EP0982030A3 (en) * | 1998-08-17 | 2000-05-10 | Pfizer Products Inc. | 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands |
US6284759B1 (en) * | 1998-09-30 | 2001-09-04 | Neurogen Corporation | 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands |
EP1117663A2 (en) * | 1998-09-30 | 2001-07-25 | Neurogen Corporation | 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
WO2001000604A1 (en) * | 1999-06-30 | 2001-01-04 | Santen Pharmaceutical Co., Ltd. | Brain sigma-1 receptor-binding ligand |
WO2001074810A2 (en) * | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
ATE361297T1 (de) | 2000-03-31 | 2007-05-15 | Ortho Mcneil Pharm Inc | Phenyl-substituierte imidazopyridine |
GB0203299D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel compounds |
WO2004022060A2 (en) | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
US9017724B2 (en) | 2004-02-24 | 2015-04-28 | The General Hospital Corporation | Catalytic radiofluorination |
US8257680B1 (en) | 2004-02-24 | 2012-09-04 | The General Hospital Corporation | Catalytic radiofluorination |
EP2388017B1 (en) * | 2004-02-24 | 2014-12-24 | The General Hospital Corporation | Catalytic radiofluorination |
US7731940B2 (en) | 2006-01-25 | 2010-06-08 | The Regents Of The University Of California | Compositions and methods related to serotonin 5-HT1A receptors |
EP3231804B1 (en) | 2008-03-21 | 2021-03-03 | The General Hospital Corporation | Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
CN109843293A (zh) * | 2016-08-26 | 2019-06-04 | 百时美施贵宝公司 | 吲哚胺2,3-双加氧酶的抑制剂及其使用方法 |
PT109740B (pt) * | 2016-11-14 | 2020-07-30 | Hovione Farmaciencia Sa | Processo para a preparação de brometo de umeclidínio |
KR20210091865A (ko) * | 2020-01-14 | 2021-07-23 | 서울대학교산학협력단 | 혈관생성 저해 효과를 가지는 n-페닐벤조티아졸-2-아민 화합물 및 그를 포함하는 약제학적 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985005359A1 (en) * | 1984-05-22 | 1985-12-05 | Sumitomo Chemical Company, Limited | Novel radioactive iodospiroperidol and process for its preparation |
AU620327B2 (en) * | 1987-04-08 | 1992-02-20 | Salutar, Inc. | Amyloidosis and alzheimer's disease diagnostic assay and reagents therefor |
US4929618A (en) * | 1988-03-25 | 1990-05-29 | Ube Industries, Ltd. | Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same |
FR2656609B1 (fr) * | 1989-12-28 | 1992-03-27 | Synthelabo | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. |
US5731438A (en) * | 1996-08-01 | 1998-03-24 | Isis Pharmaceuticals, Inc. | N-(aminoalkyl)-and/or N-(amidoalkyl)-dinitrogen heterocycles |
-
1997
- 1997-05-01 TW TW086105767A patent/TW593290B/zh not_active IP Right Cessation
- 1997-05-02 CZ CZ19983553A patent/CZ295639B6/cs not_active IP Right Cessation
- 1997-05-02 US US09/180,369 patent/US6103725A/en not_active Expired - Lifetime
- 1997-05-02 BR BR9709065A patent/BR9709065A/pt not_active IP Right Cessation
- 1997-05-02 DE DE69730962T patent/DE69730962T2/de not_active Expired - Lifetime
- 1997-05-02 EA EA199801000A patent/EA001360B1/ru not_active IP Right Cessation
- 1997-05-02 NZ NZ332309A patent/NZ332309A/xx unknown
- 1997-05-02 AU AU29560/97A patent/AU710175B2/en not_active Ceased
- 1997-05-02 JP JP54053597A patent/JP3237759B2/ja not_active Expired - Lifetime
- 1997-05-02 SK SK1532-98A patent/SK282919B6/sk not_active IP Right Cessation
- 1997-05-02 DE DE69737217T patent/DE69737217T2/de not_active Expired - Lifetime
- 1997-05-02 HU HU9902993A patent/HUP9902993A3/hu unknown
- 1997-05-02 WO PCT/EP1997/002505 patent/WO1997043271A1/en active IP Right Grant
- 1997-05-02 KR KR1019980707914A patent/KR100330699B1/ko not_active IP Right Cessation
- 1997-05-02 IL IL12696897A patent/IL126968A0/xx not_active IP Right Cessation
- 1997-05-02 EP EP03075959A patent/EP1325917B1/en not_active Expired - Lifetime
- 1997-05-02 AT AT03075959T patent/ATE350373T1/de not_active IP Right Cessation
- 1997-05-02 EE EE9800378A patent/EE03563B1/xx not_active IP Right Cessation
- 1997-05-02 TR TR1998/02253T patent/TR199802253T2/xx unknown
- 1997-05-02 ES ES97923913T patent/ES2230605T3/es not_active Expired - Lifetime
- 1997-05-02 AT AT97923913T patent/ATE277917T1/de not_active IP Right Cessation
- 1997-05-02 ES ES03075959T patent/ES2279923T3/es not_active Expired - Lifetime
- 1997-05-02 EP EP97923913A patent/EP0912533B1/en not_active Expired - Lifetime
- 1997-05-02 CA CA002253453A patent/CA2253453C/en not_active Expired - Fee Related
- 1997-05-02 PL PL97329849A patent/PL190721B1/pl not_active IP Right Cessation
- 1997-05-02 CN CN97194515A patent/CN1074766C/zh not_active Expired - Lifetime
- 1997-05-07 MY MYPI97002022A patent/MY117852A/en unknown
- 1997-05-09 AR ARP970101955A patent/AR007079A1/es active IP Right Grant
- 1997-05-09 ID IDP971546A patent/ID16889A/id unknown
- 1997-05-09 ZA ZA974053A patent/ZA974053B/xx unknown
-
1998
- 1998-10-07 BG BG102819A patent/BG64097B1/bg unknown
- 1998-11-09 NO NO19985227A patent/NO311027B1/no unknown
-
1999
- 1999-08-16 HK HK03109371A patent/HK1057044A1/xx not_active IP Right Cessation
- 1999-08-16 HK HK99103545A patent/HK1018457A1/xx not_active IP Right Cessation
-
2000
- 2000-06-27 US US09/604,427 patent/US6224849B1/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006117677A (ja) * | 2004-10-22 | 2006-05-11 | Bioprojet | 新規のアリールピペラジン誘導体 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000503667A (ja) | アルキルアミノベンゾチアゾールおよび―ベンゾキサゾール誘導体 | |
EP0912552B1 (en) | 2,4-diaminopyrimidine derivates as dopamine d4 receptor antagonists | |
EP1831173B1 (en) | Tetrahydroisoquinoline compounds for treatment of cns disorders | |
JP7094989B2 (ja) | シクロプロピルウレアホルミルペプチド2受容体およびホルミルペプチド1受容体アゴニスト | |
CZ295410B6 (cs) | Polymorfní forma 2-(R)-(1-(R)-(3,5-bis(trifluormetyl)fenyl)ethoxy)-3-(S)-(4-fluor)fenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazol)methylmorfolinu s antagonistickým účinkem na tachykininové receptory | |
JP2000502689A (ja) | タキキニンアンタゴニストとしてのn―アシル―2―置換―4―(ベンゾイミダゾリル―またはイミダゾピリジニル―置換残基)―ピペリジン | |
JP2001515899A (ja) | テトラヒドロガンマ−カルボリン類 | |
JP3287577B2 (ja) | 1,2,3,4―テトラヒドロ―ベンゾフロ[3,2―c]ピリジン誘導体 | |
JP2008509961A (ja) | 5−ht7受容体アンタゴニスト | |
TWI258480B (en) | Novel piperidinecarboxamide derivatives, a method for their preparation and pharmaceutical compositions containing them | |
TWI244485B (en) | Tricyclic Delta3-piperidines as pharmaceuticals | |
JP4580555B2 (ja) | α2アンタゴニストとしてのベンゾチエノ[3,2−c]ピリジン類 | |
TW201026691A (en) | Biaryl spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators | |
AU708344C (en) | 2,4-diaminopyrimidine derivates as dopamine D4 receptor antagonists | |
JP2010536919A (ja) | ノルエピネフリン、セロトニンまたはドーパミン再取り込み阻害剤として有用な3−アザビシクロ(4.1.0)ヘプタン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071005 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081005 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091005 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091005 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101005 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111005 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121005 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131005 Year of fee payment: 12 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |